Cytogen, Inc. (KOSDAQ:217330)
4,640.00
-235.00 (-4.82%)
At close: Mar 6, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 107.04 billion as of March 6, 2026. Its market cap has increased by 5.94% in one year.
Market Cap
107.04B
Enterprise Value
89.95B
Revenue
25.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,640.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 107.04B, an increase of 21.79%. That is a compound annual growth rate of 2.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Panagene | 92.99B |
| GENINUS | 140.91B |
| Green Cross Medical Science | 79.03B |
| Protia | 63.87B |
| Seoulin Bioscience | 56.23B |
| GeneMatrix | 45.27B |
| Dx & Vx | 401.10B |
| 3billion | 451.33B |